464 related articles for article (PubMed ID: 27941052)
21. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
Chung J; An SH; Kang SW; Kwon K
PLoS One; 2016; 11(1):e0147839. PubMed ID: 26807573
[TBL] [Abstract][Full Text] [Related]
22. Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology.
Adachi T
Adv Pharmacol; 2010; 59():165-95. PubMed ID: 20933202
[TBL] [Abstract][Full Text] [Related]
23. Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis and affects genes involved in vascular remodelling and inflammation.
Bjørnholm KD; Skovsted GF; Mitgaard-Thomsen A; Rakipovski G; Tveden-Nyborg P; Lykkesfeldt J; Povlsen GK
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):103-114. PubMed ID: 32896073
[TBL] [Abstract][Full Text] [Related]
24. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.
Kaur R; Kaur M; Singh J
Cardiovasc Diabetol; 2018 Aug; 17(1):121. PubMed ID: 30170601
[TBL] [Abstract][Full Text] [Related]
25. Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis.
Yamagata K
J Cardiovasc Pharmacol; 2020 Apr; 75(4):292-298. PubMed ID: 31895874
[TBL] [Abstract][Full Text] [Related]
26. T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis.
Kyriakakis E; Philippova M; Joshi MB; Pfaff D; Bochkov V; Afonyushkin T; Erne P; Resink TJ
Cell Signal; 2010 Sep; 22(9):1308-16. PubMed ID: 20457250
[TBL] [Abstract][Full Text] [Related]
27. Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.
Wang Y; Chen LM; Liu ML
Acta Pharmacol Sin; 2014 Apr; 35(4):433-43. PubMed ID: 24608676
[TBL] [Abstract][Full Text] [Related]
28. Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis.
Kadlec AO; Chabowski DS; Ait-Aissa K; Gutterman DD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1467-74. PubMed ID: 27312223
[TBL] [Abstract][Full Text] [Related]
29. Endoplasmic reticulum stress, redox, and a proinflammatory environment in athero-susceptible endothelium in vivo at sites of complex hemodynamic shear stress.
Davies PF; Civelek M
Antioxid Redox Signal; 2011 Sep; 15(5):1427-32. PubMed ID: 21126204
[TBL] [Abstract][Full Text] [Related]
30. l-thyroxine attenuates extracellular Hsp90α-induced vascular endothelial calcification in diabetes mellitus, as revealed by parallel metabolic profiles.
Ding X; Qiu Y; Wu G; Li S; Cai M; Liang Y; Li D; Luo X; Meng J; Yang R; Cao Y; Gao F; Xue Y; Zou F; Zou M
Atherosclerosis; 2024 May; 392():117527. PubMed ID: 38583286
[TBL] [Abstract][Full Text] [Related]
31. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress and the development of endothelial dysfunction.
Battson ML; Lee DM; Gentile CL
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H355-H367. PubMed ID: 27923788
[TBL] [Abstract][Full Text] [Related]
33. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
Gimbrone MA; García-Cardeña G
Circ Res; 2016 Feb; 118(4):620-36. PubMed ID: 26892962
[TBL] [Abstract][Full Text] [Related]
34. Endothelial damage and stem cell repair in atherosclerosis.
Bai X; Wang X; Xu Q
Vascul Pharmacol; 2010; 52(5-6):224-9. PubMed ID: 20156585
[TBL] [Abstract][Full Text] [Related]
35. Reversibility of endothelial dysfunction in diabetes: role of polyphenols.
Suganya N; Bhakkiyalakshmi E; Sarada DV; Ramkumar KM
Br J Nutr; 2016 Jul; 116(2):223-46. PubMed ID: 27264638
[TBL] [Abstract][Full Text] [Related]
36. Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis.
Sharma A; Sellers S; Stefanovic N; Leung C; Tan SM; Huet O; Granville DJ; Cooper ME; de Haan JB; Bernatchez P
Diabetes; 2015 Nov; 64(11):3937-50. PubMed ID: 26116699
[TBL] [Abstract][Full Text] [Related]
37. Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications.
Banarjee R; Sharma A; Bai S; Deshmukh A; Kulkarni M
J Proteomics; 2018 Sep; 187():69-79. PubMed ID: 29935336
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
Zimmerman MA; Flores SC
J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
[TBL] [Abstract][Full Text] [Related]
39. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
40. PPARδ Is Required for Exercise to Attenuate Endoplasmic Reticulum Stress and Endothelial Dysfunction in Diabetic Mice.
Cheang WS; Wong WT; Zhao L; Xu J; Wang L; Lau CW; Chen ZY; Ma RC; Xu A; Wang N; Tian XY; Huang Y
Diabetes; 2017 Feb; 66(2):519-528. PubMed ID: 27856609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
